The Vanishing Stenosis: ST Elevation Myocardial Infarction and Rhythm Disturbance due to Coronary Artery Spasm-Case Report and Review of the Literature by Gosai, J. et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 132902, 4 pages
doi:10.1155/2010/132902
Case Report
The Vanishing Stenosis: ST Elevation Myocardial
Infarction and Rhythm Disturbance due to Coronary Artery
Spasm—Case Report and Review of the Literature
J. Gosai, C. J. Malkin, and E. D. Grech
Department of Cardiology, Sheﬃeld Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheﬃeld S5 7AU, UK
Correspondence should be addressed to J. Gosai, jiv@doctors.org.uk
Received 4 October 2009; Accepted 8 February 2010
Academic Editor: Robert Soufer
Copyright © 2010 J. Gosai et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A 62-year-old lady was admitted with clinical and electrocardiograph features of acute myocardial infarction. Urgent coronary
arteriography was performed, demonstrating a single discrete stenosis of one coronary artery. Following intracoronary injection
of GTN, this stenosis completely resolved, as the symptoms did. The causes of acute myocardial infarction with normal coronary
arteries are reviewed.
1. Case Presentation
A 62-year-old lady with a history of treated hypothyroidism
and obesity presented with a 12 hour history of severe central
chest pain radiating to her left arm and not responding
to sublingual nitrates. On arrival, she appeared in severe
pain, and electrocardiogram (ECG) showed intermittent
heart block and ST elevation in leads II, III and aVF with
ST depression and deep T wave inversions in leads V2—
V5 (Figure 1). A diagnosis of infero-posterior ST elevation
myocardial infarction was made and she was transferred to
the cardiac catheterisation suite for primary angioplasty.
The patient had no known risk factors for coronary
artery disease except for obesity (BMI 44). She had previously
had a diagnosis of ischaemic heart disease and angina
and previous ECGs had shown T wave inversion in the
inferolateral leads. There had been extensive correspondence
about her problematic exertional chest pain and non-
compliance with therapy.
Coronary angiography showed an 80% discrete stenosis
of the proximal circumflex artery (Figure 2).
Initially the circumflex lesion was crossed with a hydro-
philic floppy guide wire, and 200 micrograms intracoronary
glyceryl trinitrate (GTN) was administered. Following this,
there was an immediate and complete resolution of the appa-
rent luminal stenosis, with marked increase in the calibre of
the coronary artery throughout. The ECG and symptoms
immediately improved (Figures 3 and 4).
The patient was treated overnight with intravenous
GTN infusion and converted to a long acting oral nitrate
preparation. She had no further symptoms and troponin I
was measured at 0.07 ng/mL at 12 hours post pain (normal
range <0.05). The patient was discharged. At 6 months she
was reported to have few ongoing symptoms and improved
exercise tolerance.
2. Discussion
Coronary spasm as a mimic of acute coronary syndrome
including acute myocardial infarction (AMI) is a well doc-
umented phenomenon, associated with chest pain, hospital
admissions and treatment as for atherosclerotic heart disease
including angiography. It can also cause life threatening
arrhythmia and other complications related to ischaemic
myocardium.
Coronary spasm may occur in normal coronary arter-
ies, but is more common in vessels with non-obstructive
atheroma which do not cause significant flow limitation at
angiography but reduce the reserve capacity for flow through
the vessel. The prevalence is higher in Japanese and Korean
populations than in the Western population, probably due
to a combination of genetic and environmental factors.
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Figure 1: ECG demonstrating Inferior ST elevation, T wave
inversions.
LAO cranial. 
Figure 2
Polymorphisms of the endothelial nitric oxide synthase and
angiotensin II type 1 receptor have been put forward as pro-
vasospastic with reduced endothelial nitric oxide activity and
increased inflammatory markers. Several authors have also
suggested that smoking is a strong independent risk factor
for coronary artery spasm. This spasm may be dynamic,
and can involve both large and small coronary arteries,
sometimes multiple. This may explain acute myocardial
infarction without a definite 100% stenosis seen.
The recently reported CASPAR study by Ong et al. took a
large series of patients presenting with chest pain progressing
to coronary angiography. 28% (138 of 488) had no demon-
strable culprit lesion, and of these 86% underwent acetyl-
choline provocation testing. 49% (n= 42) demonstrated
evidence of significant coronary spasm defined as a reduction
in vessel calibre of at least 75% [1].
Animal models have demonstrated upregulation of
coronary artery Rho-Kinase (ROCK) activity, resulting
in increased myosin light chain phosphorylation (via
myosin light chain phosphatase inhibition). An abnormal
vasoconstrictor response to acetylcholine is seen. This forms
the basis of the ergonovine provocation test used to assess
propensity to vasospasm in those with chest pain and non
flow limiting disease at angiography.
Table 1: Associations of coronary artery vasospasm.
Smoking
Thyroid dysfunction
Raynaud’s phenomenon
Scleroderma
Cold exposure
Migraine (conflicting evidence)
Drugs Cocaine
Ethanol
Amphetamines
Calcium channel blockers
(withdrawal)
Capecitabine
Martı´nez-Selle´s et al. demonstrated ergonovine induced
spasm in 20% of 346 patients who had presented with
chest pain and normal coronary arteries, and that inducible
vasospasm was a positive predictor for future presentation
with vasospasm. However the same authors also found
that the baseline ECG and any ECG changes seen did not
correlate with the presence of vasospasm. Hattori et al. also
describe cases of an ergonovine provocation test producing
vasospasm, and subsequent delivery of GTN failing to reverse
or possibly even exacerbating this [2–6].
Intense vasospasm is seen in AMI following cocaine
use (and certain amphetamine like compounds such as
Catha edulis—khat), capecitabine administration, ethanol
intoxication and following abrupt withdrawal of calcium
channel blocking drugs. The alpha-adrenoceptor agonist
eﬀects of cocaine were thought to be the primary mechanism
for cocaine induced coronary spasm, although it seems
likely that this occurs in individuals predisposed to coronary
spasm. There are case reports of pseudoephedrine induced
acute myocardial infarction with normal coronary arteries
in those using the drug for viral upper respiratory tract
infections [5, 7–9] (see Table 1).
The anti-migraine triptan drugs are contra-indicated in
those with known atherosclerotic coronary artery disease,
and are though to induce vasoconstriction. However a recent
study to quantify this showed only a modest vasoconstrictive
eﬀect of up to 6.8% of coronary artery diameter with two
diﬀerent triptan drugs in those with stable angina [10].
Unsurprisingly, associations have been made between
Raynaud’s disease, or limited systemic sclerosis (sclero-
derma) and coronary artery spasm, as well as one study
finding an increased prevalence of migraine in those with
coronary vasospasm (but not an increased prevalence of
Raynaud’s). As such, in one case report, iloprost was used
as therapy and appeared to reverse the coronary spasm. In
another, an emotional upset was thought to have triggered
the event in a patient with CREST and acquired protein S
deficiency. One small study of patients with documented
coronary artery spasm demonstrated reproducible myocar-
dial perfusion defects when the patients were exposed to
the cold. Control subjects with atherosclerosis did not. The
defects were reversed on rewarming [11–13].
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Measurement results:
QRS: 86 ms
QT/QTcB: 394/451 ms
PR: 180 ms
P: 120 ms
PR/PP: 784/755 ms
P/QRS/T: 58/33/57 degrees
Interpretation:
Unconfirmed report.
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Figure 3: ECG immediately post angiography and IC GTN.
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Figure 4
Other associations with coronary artery spasm are hyper-
thyroidism (classically described in young Asian women and
resolving on establishing euthyroidism). There are also a two
case reports of hypothyroidism associated with Raynaud’s
phenomenon and coronary artery spasm [14–18].
In the acute setting, nitrates are the preferred treatment
for coronary spasm, although eﬃcacy is variable. Rarely
other interventions are required in the context of spasm
causing myocardial infarction.
Maintenance therapy is based on nitrates and calcium
channel blockers. Ninomiya et al. demonstrated in a small
study of patients on either long term long acting nitrates or
calcium channel blocker with anginal symptoms and normal
or near normal coronary arteries and segments displaying
a vasoconstrictive response to acetylcholine that the degree
of flow restriction when challenged with acetylcholine was
greater in the nitrate group than the calcium channel blocker
group. The conclusions were that treatment with calcium
channel blockers may be more eﬀective than nitrates in the
long term. Beta blockers should be avoided, as there is a risk
of precipitating spasm with these [19].
Learning Points. (i) Coronary artery spasm well is a docu-
mented cause of chest pain and presentation as acute coro-
nary syndrome. (ii) Coronary arteriography may demon-
strate normal arteries or disease at a level inconsistent
with symptoms. The stenosis may be dynamic, involving
large or small and often multiple coronary arteries. (iii)
It can cause acute myocardial infarction, including sudden
death. (iv) Treatment acutely is with nitrate. (v) Treatment
acutely is with nitrate. (vi) It is most commonly seen
in Asian populations, young women and smokers. (vii)
Other associations include drugs, thyroid dysfunction, and
scleroderma. The underlying pathophysiology is unclear but
thought to be EDRF related. (ix) Maintenance treatment
is with calcium channelblocking drugs or nitrates. Beta
blockers are best avoided.
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